Johnson & Johnson (BVMF:JNJB34)

Market Cap	2.75T
Revenue (ttm)	492.28B
Net Income (ttm)	134.19B
Shares Out	n/a
EPS (ttm)	55.28
PE Ratio	20.48
Forward PE	18.65
Dividend	1.26 (1.63%)
Ex-Dividend Date	Nov 25, 2025

Volume	5,837
Average Volume	3,388
Open	76.20
Previous Close	76.78
Day's Range	75.87 - 77.46
52-Week Range	54.62 - 77.94
Beta	0.35
RSI	56.97
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: JNJB34

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD